Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients

NCT01897714 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
75
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated at median 46-48 months long term follow-up and mature overall survival follow-up data.

Conditions

Interventions

Sponsor

Oncopeptides AB